Skip to main content
logo
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.14
-0.16 (-2.54%)
Oct 30, 2026, 4:00 PM EDT - Market closed

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
637346411436389496
Market Cap Growth
60.92%-15.71%-5.92%12.22%-21.59%-
Enterprise Value
330202255308298631
Last Close Price
6.145.458.228.8610.5016.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.022.532.701.931.993.26
P/TBV Ratio
2.022.532.701.931.993.26

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.130.120.090.110.01
Net Debt / Equity Ratio
-0.97-0.93-0.87-0.91-0.86-0.97
Net Debt / EBITDA Ratio
2.241.141.392.472.844.30
Net Debt / FCF Ratio
2.971.491.633.203.024.29
Quick Ratio
16.657.8510.1318.3018.0620.27
Current Ratio
16.828.1510.7718.7618.8120.90
Return on Equity (ROE)
-53.49%-73.52%-46.01%-36.26%-33.78%-41.07%
Return on Assets (ROA)
-31.24%-40.06%-27.46%-22.18%-19.63%-24.19%
Return on Capital Employed (ROCE)
-42.00%-74.70%-57.40%-35.00%-28.20%-23.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-28.87%-30.68%-21.17%-17.51%-15.11%-7.11%
FCF Yield
-16.23%-24.61%-19.74%-14.79%-14.32%-6.96%
Buyback Yield / Dilution
-42.27%-21.52%-25.32%-32.34%-480.18%-1305.21%
SEC Filings: 10-K · 10-Q